Subclinical sacroiliitis in inflammatory bowel disease: A clinical and follow-up study

Citation
R. Queiro et al., Subclinical sacroiliitis in inflammatory bowel disease: A clinical and follow-up study, CLIN RHEUMA, 19(6), 2000, pp. 445-449
Citations number
20
Categorie Soggetti
Rheumatology
Journal title
CLINICAL RHEUMATOLOGY
ISSN journal
07703198 → ACNP
Volume
19
Issue
6
Year of publication
2000
Pages
445 - 449
Database
ISI
SICI code
0770-3198(2000)19:6<445:SSIIBD>2.0.ZU;2-D
Abstract
The aim of this study was to evaluate the clinical features, evolution and reliability of spondyloarthropathy criteria in a subset of patients with su bclinical sacroiliitis and inflammatory bowel disease (IBD). All patients w ith IBD (n 62) attending a gastroenterology clinic from a referral centre w ere included to assess the prevalence of articular involvement. Patients we re evaluated according to a specific protocol designed for the study, which included epidemiological and clinical variables, physical examination and radiological assessment. Only those with subclinical sacroiliitis were foll owed prospectively for 4 years. This group was visited every 6 months with the same initial protocol. Sacroiliac joints were studied using frontal and oblique X-ray views and graded according to New York criteria. HLA B27 typ ing was performed by serological methods in all patients and in 80 healthy controls. The reliability of Amor and ESSG criteria for spondyloarthropathy was evaluated. Fifteen patients (24%) presented with isolated subclinical sacroiliitis. In this group a higher frequency of peripheral arthritis and erythema nodosum was observed (p = NS compared to those without sacroiliiti s). Most cases (60%) were grade II unilateral sacroiliitis. Three patients were HLA B27+ (p>0.05 compared to healthy controls). The resultant sensitiv ity of Amor's and ESSG criteria ranged from 40% to 46%. An unexpectedly hig h freuqency (9.5%) of psoriasis was observed in the whole group. There is a high prevalence of isolated subclinical sacroiliitis in IBD. This may repr esent a forme fruste of enteropathic ankylosing spondylitis, a stunted form of axial involvement because of therapy, or a third category of rheumatic disease associated with IBD. It may also represent a common characteristic of spondyloarthropathies, rather than a specific finding of IBD. The recent ly developed spondyloarthropathy criteria are not particularly helpful for the diagnosis of this milder form of spondyloarthropathy.